IL1A and rheumatoid arthritis: IL-1 blocking agents are used for the treatment of different rheumatic diseases (including RA and gout) and autoinflammatory disorders such as cryopyrin-associated periodic syndrome, adult-onset Still’s disease, systemic-onset juvenile idiopathic arthritis, and familial Mediterranean fever [154,155].